In recent trading, shares of Supernus Pharmaceuticals Inc (Symbol: SUPN) have crossed above the average analyst 12-month target price of $39.25, changing hands for $39.41/share. When a stock ...

Supernus (SUPN) Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has approved an update for the label for Qelbree to include new pharmacodynamic data in Section 12.2. The ...

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share... MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX ...

PHOENIX (AZFamily) — A busy road is closed after a man was struck by a vehicle in the midst of Phoenix rush hour early Wednesday morning. Authorities say the collision happened just before 6:30 ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Still, the busy couple have found a way to balance their ever-changing personal and professional lives. "We don't travel as much with the girls," Jason tells PEOPLE. "We go back and forth because ...

JMB Travel has announced a new route between Hamilton in South Lanarkshire to Glasgow's Buchanan Street Bus Station. The brand-new X1 service runs from Farm Road in Hillhouse, Hamilton to Buchanan Bus ...

Minimal work is required, but busy day chili tastes like you cooked all day. Elizabeth Mervosh is a recipe tester and developer for the Meredith Food Studios in Birmingham, Alabama and tests and ...

Lecturer in Criminal Justice and Social Policy, School for Business and Society, University of York British MP Jess Phillips describing the online attacks she has received from Elon Musk in recent ...

In a report released yesterday, Andrew Tsai from Jefferies reiterated a Buy rating on Supernus Pharmaceuticals (SUPN – Research Report), with a price target of $40.00. The company’s shares ...

Better yet, you'd like to see the share price move up more than the market average. Unfortunately for shareholders, while the Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) share price is up 57% in the ...